Furthermore, the results showed that FOXC1 can promote growth of GC by modulating the tumor cell cycle, as mediated by c-MYC and cyclin D1, further supporting the role of FOXC1 in GC progression (Wang et al., 2018, 2020). Here, CCND1 is linked to gastric cancer.